Fetomaternal alloimmune thrombocytopenia: the questions that still remain.
Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.
Althaus
Janyne
J
Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD 21287, USA. jalthau1@jhmi.edu
Blakemore
Karin J
KJ
D005260:Female; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000628:therapy*; D011296:Prenatal Diagnosis / Q000379:methods; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D013997:Time Factors